Aadi Total Debt To Capitalization from 2010 to 2024

AADI Stock  USD 1.90  0.06  3.06%   
Aadi Bioscience's Total Debt To Capitalization is decreasing with slightly volatile movements from year to year. Total Debt To Capitalization is predicted to flatten to 0.06. For the period between 2010 and 2024, Aadi Bioscience, Total Debt To Capitalization quarterly trend regression had median of  0.01 and r-value of (0.39). View All Fundamentals
 
Total Debt To Capitalization  
First Reported
2010-12-31
Previous Quarter
0.0625919
Current Value
0.0595
Quarterly Volatility
2.75153258
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Aadi Bioscience financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Aadi main balance sheet or income statement drivers, such as Other Operating Expenses of 101.1 M, Total Operating Expenses of 98.2 M or Interest Expense of 224.8 K, as well as many exotic indicators such as Price To Sales Ratio of 2.12, Dividend Yield of 0.0164 or PTB Ratio of 0.54. Aadi financial statements analysis is a perfect complement when working with Aadi Bioscience Valuation or Volatility modules.
  
This module can also supplement Aadi Bioscience's financial leverage analysis and stock options assessment as well as various Aadi Bioscience Technical models . Check out the analysis of Aadi Bioscience Correlation against competitors.
For more detail on how to invest in Aadi Stock please use our How to Invest in Aadi Bioscience guide.

Latest Aadi Bioscience's Total Debt To Capitalization Growth Pattern

Below is the plot of the Total Debt To Capitalization of Aadi Bioscience over the last few years. It is Aadi Bioscience's Total Debt To Capitalization historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Aadi Bioscience's overall financial position and show how it may be relating to other accounts over time.
Total Debt To Capitalization10 Years Trend
Slightly volatile
   Total Debt To Capitalization   
       Timeline  

Aadi Total Debt To Capitalization Regression Statistics

Arithmetic Mean(0.01)
Coefficient Of Variation(19,450)
Mean Deviation1.83
Median0.01
Standard Deviation2.75
Sample Variance7.57
Range9.9459
R-Value(0.39)
Mean Square Error6.89
R-Squared0.16
Significance0.15
Slope(0.24)
Total Sum of Squares105.99

Aadi Total Debt To Capitalization History

2024 0.0595
2023 0.0626
2022 0.0104
2021 0.004416
2020 -4.71
2017 0.004631
2016 -3.04

About Aadi Bioscience Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Aadi Bioscience income statement, its balance sheet, and the statement of cash flows. Aadi Bioscience investors use historical funamental indicators, such as Aadi Bioscience's Total Debt To Capitalization, to determine how well the company is positioned to perform in the future. Although Aadi Bioscience investors may use each financial statement separately, they are all related. The changes in Aadi Bioscience's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Aadi Bioscience's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Aadi Bioscience Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Aadi Bioscience. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Total Debt To Capitalization 0.06  0.06 

Pair Trading with Aadi Bioscience

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Aadi Bioscience position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aadi Bioscience will appreciate offsetting losses from the drop in the long position's value.

Moving together with Aadi Stock

  0.69ERAS Erasca Inc Financial Report 20th of May 2024 PairCorr
  0.72BMY Bristol Myers Squibb Financial Report 25th of April 2024 PairCorr

Moving against Aadi Stock

  0.75AMGN Amgen Inc Financial Report 25th of April 2024 PairCorr
  0.74BIIB Biogen Inc Financial Report 23rd of April 2024 PairCorr
  0.59VRTX Vertex Pharmaceuticals Financial Report 6th of May 2024 PairCorr
  0.47ABVC ABVC BiopharmaPairCorr
The ability to find closely correlated positions to Aadi Bioscience could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Aadi Bioscience when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Aadi Bioscience - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Aadi Bioscience to buy it.
The correlation of Aadi Bioscience is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Aadi Bioscience moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Aadi Bioscience moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Aadi Bioscience can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Aadi Bioscience offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Aadi Bioscience's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Aadi Bioscience Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Aadi Bioscience Stock:
Check out the analysis of Aadi Bioscience Correlation against competitors.
For more detail on how to invest in Aadi Stock please use our How to Invest in Aadi Bioscience guide.
Note that the Aadi Bioscience information on this page should be used as a complementary analysis to other Aadi Bioscience's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.

Complementary Tools for Aadi Stock analysis

When running Aadi Bioscience's price analysis, check to measure Aadi Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aadi Bioscience is operating at the current time. Most of Aadi Bioscience's value examination focuses on studying past and present price action to predict the probability of Aadi Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aadi Bioscience's price. Additionally, you may evaluate how the addition of Aadi Bioscience to your portfolios can decrease your overall portfolio volatility.
Money Managers
Screen money managers from public funds and ETFs managed around the world
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Is Aadi Bioscience's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aadi Bioscience. If investors know Aadi will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aadi Bioscience listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.44)
Revenue Per Share
0.905
Quarterly Revenue Growth
0.21
Return On Assets
(0.28)
Return On Equity
(0.50)
The market value of Aadi Bioscience is measured differently than its book value, which is the value of Aadi that is recorded on the company's balance sheet. Investors also form their own opinion of Aadi Bioscience's value that differs from its market value or its book value, called intrinsic value, which is Aadi Bioscience's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aadi Bioscience's market value can be influenced by many factors that don't directly affect Aadi Bioscience's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aadi Bioscience's value and its price as these two are different measures arrived at by different means. Investors typically determine if Aadi Bioscience is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aadi Bioscience's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.